Unlearn Signs Multi-Year Collaboration with Merck KGaA, Darmstadt, Germany to Accelerate Immunology Trials using Twintelligent RCTs™
Collaborators will leverage AI-generated Digital Twins to enable smaller, more efficient pivotal clinical trials. February 16, 2022 07:30 AM Eastern Standard Time SAN FRANCISCO–(BUSINESS WIRE)–Unlearn®, developer of the Twintelligent RCT™, today announced...